RT Journal Article
SR Electronic
T1 Underrecognition of Fecal Incontinence in Systemic Sclerosis: Discrepancies Between the Rome IV Diagnostic Questionnaires and the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.2025-1226
DO 10.3899/jrheum.2025-1226
A1 Shan, Sam
A1 Seaton, Kate
A1 Basnayake, Chamara
A1 Ross, Laura
YR 2026
UL http://www.jrheum.org/content/early/2026/02/09/jrheum.2025-1226.abstract
AB Gastrointestinal (GI) involvement in systemic sclerosis (SSc) is common, with up to 87% of people affected.1 Of all SSc manifestations, GI disease has the greatest impact on quality of life.2